openPR Logo

Press Releases from DelveInsight Business Research LLP (5010 total)

Primary Open Angle Glaucoma Therapeutics Market Size in 7MM is expected to grow …

DelveInsight "Primary Open Angle Glaucoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Primary Open Angle Glaucoma, historical and forecasted

Meniere's Disease Therapeutics Market Size in 7MM is expected to grow at a decen …

DelveInsight's "Meniere's Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Meniere's Disease, historical and forecasted epidemiology as well as

Acquired Blepharoptosis Therapeutics Market Size in 7MM is expected to grow at a …

DelveInsight's "Acquired Blepharoptosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Acquired Blepharoptosis, historical and forecasted epidemiology as well as

Optic Neuropathy Therapeutics Market Size in 7MM is expected to grow at a decent …

DelveInsight "Optic Neuropathy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Optic Neuropathy, historical and forecasted epidemiology as well as

Retinal Neovascularization Therapeutics Market Size in 7MM is expected to grow a …

DelveInsight's "Retinal Neovascularization Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Retinal Neovascularization, historical and forecasted epidemiology as well as

Cataract Therapeutics Market Size in 7MM is expected to grow at a decent CAGR by …

DelveInsight's "Cataract Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Cataract, historical and forecasted epidemiology as well as the Cataract

Scleritis Therapeutics Market Size in 7MM is expected to grow at a decent CAGR b …

DelveInsight's "Scleritis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Scleritis, historical and forecasted epidemiology as well as the Scleritis

Dry Age Macular Degeneration Therapeutics Market Size in 7MM is expected to grow …

DelveInsight's "Dry Age Macular Degeneration Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Dry Age Macular Degeneration, historical and forecasted

Central Retinal Vein Occlusion Therapeutics Market Size in 7MM is expected to gr …

DelveInsight's "Central Retinal Vein Occlusion Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Central Retinal Vein Occlusion, historical and forecasted

Keratoconus Therapeutics Market Size in 7MM is expected to grow at a decent CAGR …

DelveInsight's "Keratoconus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Keratoconus, historical and forecasted epidemiology as well as the Keratoconus

Graves Ophthalmopathy Therapeutics Market Size in 7MM is expected to grow at a d …

DelveInsight's " Graves Ophthalmopathy Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Graves Ophthalmopathy, historical and forecasted epidemiology as well

Wet Age-Related Macular Degeneration Therapeutics Market Size in 7MM is expected …

DelveInsight's "Wet Age-Related Macular Degeneration Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Wet Age-Related Macular Degeneration, historical and forecasted

Hay Fever Conjunctivitis Therapeutics Market Size in 7MM is expected to grow at …

DelveInsight's "Hay Fever Conjunctivitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Hay Fever Conjunctivitis, historical and forecasted epidemiology as

Dry AMD Therapeutics Market Size in 7MM is expected to grow at a decent CAGR by …

DelveInsight's "Dry AMD Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Dry AMD, historical and forecasted epidemiology as well as

Psoriasis Pipeline Analysis and Clinical Trials Assessment, 2025 by DelveInsight …

Psoriasis Pipeline constitutes 80+ key companies continuously working towards developing 80+ Psoriasis treatment therapies, analyzes DelveInsight. Psoriasis Overview: Psoriasis is a long-term inflammatory skin condition that presents

Obesity Pipeline Analysis and Clinical Trials Assessment, 2025 by DelveInsight | …

Obesity Pipeline constitutes 80+ key companies continuously working towards developing 100+ Obesity treatment therapies, analyzes DelveInsight. Obesity Overview: **Obesity** refers to the **abnormal or excessive buildup of

Ocular Hypertension Pipeline Analysis and Clinical Trials Assessment, 2025 by De …

Ocular Hypertension Pipeline constitutes 50+ key companies continuously working towards developing 75+ Ocular Hypertension treatment therapies, analyzes DelveInsight. Ocular Hypertension Overview: Ocular hypertension refers to increased pressure

Osteoarthritis Pipeline Analysis and Clinical Trials Assessment, 2025 by DelveIn …

Osteoarthritis Pipeline constitutes 100+ key companies continuously working towards developing 110+ Osteoarthritis treatment therapies, analyzes DelveInsight. Osteoarthritis Overview: Osteoarthritis (OA) is the most prevalent type of arthritis,

Pancreatic Ductal Adenocarcinoma Pipeline Analysis and Clinical Trials Assessmen …

Pancreatic Ductal Adenocarcinoma Pipeline constitutes 80+ key companies continuously working towards developing 80+ Pancreatic Ductal Adenocarcinoma treatment therapies, analyzes DelveInsight. Pancreatic Ductal Adenocarcinoma Overview: Pancreatic ductal adenocarcinoma

Prostate Cancer Pipeline Analysis and Clinical Trials Assessment, 2025 by DelveI …

Prostate Cancer Pipeline constitutes 140+ key companies continuously working towards developing 150+ Prostate Cancer treatment therapies, analyzes DelveInsight. Prostate Cancer Overview: Prostate cancer develops when cells in

Pancreatic Neuroendocrine Tumors Therapeutics Market Size in 7MM is expected to …

DelveInsight's "Pancreatic Neuroendocrine Tumors Drugs Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of Pancreatic Neuroendocrine Tumors, historical and forecasted

PD-L1 Inhibitors Therapeutics Market Size in 7MM is expected to grow at a decent …

DelveInsight's "PD-L1 Inhibitors Market Insight, Epidemiology and Market Forecast - 2034" report delivers an in-depth analysis of PD-L1 inhibitors epidemiology, market, and clinical development understanding

PD-L1 Metastatic Non-small Cell Lung Cancer Therapeutics Market Size in 7MM is e …

DelveInsight's "PD-L1 Metastatic Non-small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2032" Report delivers an in-depth understanding of the PD-L1 Metastatic Non-small Cell Lung

PEComa Therapeutics Market Size in 7MM is expected to grow at a decent CAGR by 2 …

DelveInsight's "PEComa Market Insights, Epidemiology, and Market Forecast-2034" Report delivers an in-depth understanding of the PEComa, historical and forecasted epidemiology as well as the PEComa

Pediatric Brain Tumors Therapeutics Market Size in 7MM is expected to grow at a …

DelveInsight's "Pediatric Brain Tumors Market Insights, Epidemiology, and Market Forecast-2034" Report delivers an in-depth understanding of the Pediatric Brain Tumors, historical and forecasted epidemiology as

Non-Small-Cell Lung cancer (NSCLC) Pipeline Analysis and Clinical Trials Assessm …

Non-Small-Cell Lung cancer (NSCLC) Pipeline constitutes 100+ key companies continuously working towards developing 120+ Non-Small-Cell Lung cancer (NSCLC) treatment therapies, analyzes DelveInsight. Non-Small-Cell Lung cancer (NSCLC)

Non-Alcoholic Fatty Liver Disease Pipeline Analysis and Clinical Trials Assessme …

Non-Alcoholic Fatty Liver Disease Pipeline constitutes 90+ key companies continuously working towards developing 100+ Non-Alcoholic Fatty Liver Disease treatment therapies, analyzes DelveInsight. Non-Alcoholic Fatty Liver Disease

Neuroendocrine tumors Pipeline Analysis and Clinical Trials Assessment, 2025 by …

Neuroendocrine tumors Pipeline constitutes 100+ key companies continuously working towards developing 120+ Neuroendocrine tumors treatment therapies, analyzes DelveInsight. Neuroendocrine tumors Overview: Neuroendocrine cancer, also known as a

Advanced Cancer Pain Management Therapeutics Market Size in 7MM is expected to g …

DelveInsight's "Advanced Cancer Pain Management Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Advanced Cancer Pain Management, historical and forecasted

Gastroesophageal Junction Adenocarcinoma Therapeutics Market Size in 7MM is expe …

elveInsight's "Gastroesophageal Junction Adenocarcinoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Gastroesophageal Junction Adenocarcinoma, historical and forecasted

Meningioma Therapeutics Market Size in 7MM is expected to grow at a decent CAGR …

DelveInsight's "Meningioma Market Insights, Epidemiology, and Market Forecast-2032" Report delivers an in-depth understanding of the Meningioma, historical and forecasted epidemiology as well as the Meningioma

HPV16+ Anogenital Cancers Therapeutics Market Size in 7MM is expected to grow at …

DelveInsight's "HPV16+ Anogenital Cancers Market Insights, Epidemiology, and Market Forecast-2032" Report delivers an in-depth understanding of the HPV16+ Anogenital Cancers, historical and forecasted epidemiology as

Triple Refractory Multiple Myeloma Therapeutics Market Size in 7MM is expected t …

DelveInsight's "Triple Refractory Multiple Myeloma Market Insights, Epidemiology, and Market Forecast-2032" Report delivers an in-depth understanding of the Triple Refractory Multiple Myeloma, historical and forecasted

Pediatric Brain Tumors Therapeutics Market Size in 7MM is expected to grow at a …

DelveInsight's "Pediatric Brain Tumors Market Insights, Epidemiology, and Market Forecast-2034" Report delivers an in-depth understanding of the Pediatric Brain Tumors, historical and forecasted epidemiology as

Mucosa-associated Lymphoid Tissue (MALT) Lymphoma Therapeutics Market Size in 7M …

DelveInsight's "Mucosa-associated Lymphoid Tissue (MALT) Lymphoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Mucosa-associated Lymphoid Tissue (MALT) Lymphoma, historical

Bowen's Disease Therapeutics Market Size in 7MM is expected to grow at a decent …

DelveInsight's "Bowen's Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Bowen's Disease, historical and forecasted epidemiology as well as

Parkinson's Disease Pipeline Analysis and Clinical Trials Assessment, 2025 by De …

Parkinson's Disease Pipeline constitutes 130+ key companies continuously working towards developing 150+ Parkinson's Disease treatment therapies, analyzes DelveInsight. Parkinson's Disease Overview: Parkinson's disease (PD) is a long-term,

Ocular Hypertension Pipeline Analysis and Clinical Trials Assessment, 2025 by De …

Ocular Hypertension Pipeline constitutes 50+ key companies continuously working towards developing 75+ Ocular Hypertension treatment therapies, analyzes DelveInsight. Ocular Hypertension Overview: Ocular hypertension refers to a condition

Chronic Lymphocytic Leukemia Pipeline Analysis and Clinical Trials Assessment, 2 …

Chronic Lymphocytic Leukemia Pipeline constitutes 55+ key companies continuously working towards developing 60+ Chronic Lymphocytic Leukemia treatment therapies, analyzes DelveInsight. Chronic Lymphocytic Leukemia Overview: Chronic lymphocytic leukemia

Nephrotic Syndrome Pipeline Analysis and Clinical Trials Assessment, 2025 by Del …

Nephrotic Syndrome Pipeline constitutes 3+ key companies continuously working towards developing 3+ Nephrotic Syndrome treatment therapies, analyzes DelveInsight. Nephrotic Syndrome Overview: **Nephrotic Syndrome** is a collection of

Netherton Syndrome Pipeline Analysis and Clinical Trials Assessment, 2025 by Del …

Netherton Syndrome Pipeline constitutes 5+ key companies continuously working towards developing 5+ Netherton Syndrome treatment therapies, analyzes DelveInsight. Netherton Syndrome Overview: **Netherton Syndrome (NS)** is a rare

Opioid Withdrawal Syndrome Pipeline Analysis and Clinical Trials Assessment, 202 …

Opioid Withdrawal Syndrome Pipeline constitutes 4+ key companies continuously working towards developing 4+ Opioid Withdrawal Syndrome treatment therapies, analyzes DelveInsight. Opioid Withdrawal Syndrome Overview: Opioid Withdrawal Syndrome

Parainfluenza Virus Infection Pipeline Analysis and Clinical Trials Assessment, …

Parainfluenza Virus Infection Pipeline constitutes 5+ key companies continuously working towards developing 5+ Parainfluenza Virus Infection treatment therapies, analyzes DelveInsight. Parainfluenza Virus Infection Overview: The human parainfluenza

Multiple sclerosis Pipeline Analysis and Clinical Trials Assessment, 2025 by Del …

Multiple sclerosis Pipeline constitutes 75+ key companies continuously working towards developing 80+ Multiple sclerosis treatment therapies, analyzes DelveInsight. Multiple sclerosis Overview: Multiple sclerosis (MS) is the most

Myelodysplastic Syndrome Pipeline Analysis and Clinical Trials Assessment, 2025 …

Myelodysplastic Syndrome Pipeline constitutes 120+ key companies continuously working towards developing 125+ Myelodysplastic Syndrome treatment therapies, analyzes DelveInsight. Myelodysplastic Syndrome Overview: Myelodysplastic syndrome (MDS) is a diverse

Natural Killer Cell Therapies Pipeline Analysis and Clinical Trials Assessment, …

Natural Killer Cell Therapies Pipeline constitutes 100+ key companies continuously working towards developing 140+ Natural Killer Cell Therapies treatment therapies, analyzes DelveInsight. Natural Killer Cell Therapies

Obstructive Sleep Apnea Pipeline Analysis and Clinical Trials Assessment, 2025 b …

Obstructive Sleep Apnea Pipeline constitutes 20+ key companies continuously working towards developing 21+ Obstructive Sleep Apnea treatment therapies, analyzes DelveInsight. Obstructive Sleep Apnea Overview: Obstructive Sleep Apnea

Nontuberculous Mycobacterial Infections Pipeline Analysis and Clinical Trials As …

Nontuberculous Mycobacterial Infections Pipeline constitutes 10+ key companies continuously working towards developing 10+ Nontuberculous Mycobacterial Infections treatment therapies, analyzes DelveInsight. Nontuberculous Mycobacterial Infections Overview: Nontuberculous Mycobacterial (NTM)

Myotonic Dystrophy Pipeline Analysis and Clinical Trials Assessment, 2025 by Del …

Myotonic Dystrophy Pipeline constitutes 20+ key companies continuously working towards developing 22+ Myotonic Dystrophy treatment therapies, analyzes DelveInsight. Myotonic Dystrophy Overview: Myotonic Dystrophy (DM) is the most

Food Allergy Pipeline Analysis and Clinical Trials Assessment, 2025 by DelveInsi …

Food Allergy Pipeline constitutes 25+ key companies continuously working towards developing 30+ Food Allergy treatment therapies, analyzes DelveInsight. Food Allergy Overview: Food allergies are harmful immune responses

Go To Page:    11 12 13 14 15 16 17 18 19 20